1 Search Results Found

AstraZeneca (AZN) and Gilead Sciences (GILD) $250bn merger information including expected completion date, offer price and contact details are displayed in the acquisition details table below. An invaluable buyout factsheet for traders and investors looking to trade the merger arbitrage spread.